Bioavailability and bioefficacy of polyphenols in humans. II. Review of 93 intervention studies.
For some classes of dietary polyphenols, there are now sufficient intervention studies to indicate the type and magnitude of effects among humans in vivo, on the basis of short-term changes in biomarkers. Isoflavones (genistein and daidzein, found in soy) have significant effects on bone health among postmenopausal women, together with some weak hormonal effects. Monomeric catechins (found at especially high concentrations in tea) have effects on plasma antioxidant biomarkers and energy metabolism. Procyanidins (oligomeric catechins found at high concentrations in red wine, grapes, cocoa, cranberries, apples, and some supplements such as Pycnogenol) have pronounced effects on the vascular system, including but not limited to plasma antioxidant activity. Quercetin (the main representative of the flavonol class, found at high concentrations in onions, apples, red wine, broccoli, tea, and Ginkgo biloba) influences some carcinogenesis markers and has small effects on plasma antioxidant biomarkers in vivo, although some studies failed to find this effect. Compared with the effects of polyphenols in vitro, the effects in vivo, although significant, are more limited. The reasons for this are 1) lack of validated in vivo biomarkers, especially in the area of carcinogenesis; 2) lack of long-term studies; and 3) lack of understanding or consideration of bioavailability in the in vitro studies, which are subsequently used for the design of in vivo experiments. It is time to rethink the design of in vitro and in vivo studies, so that these issues are carefully considered. The length of human intervention studies should be increased, to more closely reflect the long-term dietary consumption of polyphenols.
Williamson
Gary
G
Nutrient Bioavailability Group, Nestlé Research Center, Lausanne, Switzerland. gary.williamson@rdls.nestle.com
Manach
Claudine
C
D000328:Adult; D000368:Aged; D001682:Biological Availability; D015415:Biomarkers; D002392:Catechin / Q000008:administration & dosage / Q000493:pharmacokinetics / Q000627:therapeutic use*; D005260:Female; D005419:Flavonoids / Q000378:metabolism / Q000493:pharmacokinetics* / Q000627:therapeutic use; D044948:Flavonols / Q000008:administration & dosage / Q000493:pharmacokinetics / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D008875:Middle Aged; D010636:Phenols / Q000378:metabolism / Q000493:pharmacokinetics* / Q000627:therapeutic use; D010936:Plant Extracts / Q000008:administration & dosage / Q000493:pharmacokinetics / Q000627:therapeutic use*; D059808:Polyphenols
D015415:Biomarkers; D005419:Flavonoids; D044948:Flavonols; D010636:Phenols; D010936:Plant Extracts; D059808:Polyphenols; D002392:Catechin